NEURAXIS, INC. Interest Expense
NEURAXIS, INC. (NRXS) reported Interest Expense of $19.79 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-11
- NEURAXIS, INC. interest expense for the quarter ending 2026-06-30 was $19.79K, a 47.34% increase year-over-year.
- NEURAXIS, INC. interest expense for the quarter ending 2026-03-31 was $26.19K, a 1070.72% increase year-over-year.
- NEURAXIS, INC. interest expense for the quarter ending 2025-12-31 was $28.64K, a 1096.16% increase year-over-year.
- NEURAXIS, INC. interest expense for the quarter ending 2025-09-30 was $29.66K, a 54.14% decline year-over-year.
- NEURAXIS, INC. interest expense for fiscal 2025 was $73.97K, a 57.57% decline from fiscal 2024.
- NEURAXIS, INC. interest expense for fiscal 2024 was $174.33K, a 63.41% decline from fiscal 2023.
- NEURAXIS, INC. interest expense for fiscal 2023 was $476.42K, a 49.50% increase from fiscal 2022.
- NEURAXIS, INC. interest expense for fiscal 2022 was $318.67K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.79K 10-Q · filed 2026-08-11 | $45.98K 10-Q · filed 2026-08-11 | $74.62K derived: sum of 3 quarters · filed 2026-08-11 | $104.28K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $26.19K 10-Q · filed 2026-05-12 | $54.83K derived: sum of 2 quarters · filed 2026-05-12 | $84.49K derived: sum of 3 quarters · filed 2026-05-12 | $97.92K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $28.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $58.30K derived: sum of 2 quarters · filed 2026-03-19 | $71.73K derived: sum of 3 quarters · filed 2026-08-11 | $73.97K 10-K · filed 2026-03-19 |
| 2025-09-30 | $29.66K 10-Q · filed 2025-11-10 | $43.09K derived: sum of 2 quarters · filed 2026-08-11 | $45.33K 10-Q · filed 2025-11-10 | $47.73K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $13.43K 10-Q · filed 2026-08-11 | $15.67K 10-Q · filed 2026-08-11 | $18.07K derived: sum of 3 quarters · filed 2026-08-11 | $82.74K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $2.24K 10-Q · filed 2026-05-12 | $4.63K derived: sum of 2 quarters · filed 2026-05-12 | $69.31K derived: sum of 3 quarters · filed 2026-05-12 | $150.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $67.07K derived: sum of 2 quarters · filed 2026-03-19 | $147.77K derived: sum of 3 quarters · filed 2026-03-19 | $174.33K 10-K · filed 2026-03-19 |
| 2024-09-30 | $64.68K 10-Q · filed 2025-11-10 | $145.37K derived: sum of 2 quarters · filed 2025-11-10 | $171.93K 10-Q · filed 2025-11-10 | $194.48K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $80.70K 10-Q · filed 2025-08-12 | $107.26K 10-Q · filed 2025-08-12 | $129.80K derived: sum of 3 quarters · filed 2025-08-12 | $232.43K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $26.56K 10-Q · filed 2025-05-12 | $49.11K derived: sum of 2 quarters · filed 2025-05-12 | $151.74K derived: sum of 3 quarters · filed 2025-05-12 | $346.43K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $22.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $125.17K derived: sum of 2 quarters · filed 2025-03-20 | $319.87K derived: sum of 3 quarters · filed 2025-03-20 | $476.42K 10-K · filed 2025-03-20 |
| 2023-09-30 | $102.63K 10-Q · filed 2024-11-12 | $297.32K derived: sum of 2 quarters · filed 2024-11-12 | $453.87K 10-Q · filed 2024-11-12 | $616.38K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $194.69K 10-Q · filed 2024-08-09 | $356.38K 10-Q · filed 2024-08-09 | $513.75K derived: sum of 3 quarters · filed 2024-08-09 | $614.50K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $161.69K 10-Q · filed 2024-05-20 | $319.06K derived: sum of 2 quarters · filed 2024-05-20 | $419.81K derived: sum of 3 quarters · filed 2024-05-20 | $454.25K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $157.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $258.12K derived: sum of 2 quarters · filed 2024-04-16 | $292.57K derived: sum of 3 quarters · filed 2024-04-16 | $318.67K 10-K · filed 2024-04-16 |
| 2022-09-30 | $100.74K 10-Q · filed 2023-11-20 | $135.19K derived: sum of 2 quarters · filed 2023-11-20 | $161.29K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $34.45K 10-Q · filed 2023-09-22 | $60.55K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |